Evidence map›Paper›PMID 32232555›Full record

ArticleInternational archives of occupational and environmental health2020

Estimating the burden of lung cancer in Canada attributed to occupational radon exposure using a novel exposure assessment method.

C B Ge, J Kim, F Labrèche, E Heer, C Song, V H Arrandale, M Pahwa, C E Peters, P A Demers

Abstract read
In one paragraph

Article in International archives of occupational and environmental health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C B GeInstitute for Risk Assessment Sciences (IRAS), Utrecht University, Yalelaan 2, 3584 CM, Utrecht, Netherlands. c.b.ge@uu.nl.
J KimOccupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada.
F LabrècheInstitut de Recherche Robert-Sauvé en santé Et en sécurité du Travail, Montréal, Canada.
E HeerDepartment of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Canada.
C SongOccupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada.
V H ArrandaleOccupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada.
M PahwaOccupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada.
C E PetersCAREX Canada, Simon Fraser University, Burnaby, Canada.
P A DemersOccupational Cancer Research Centre, Cancer Care Ontario, Toronto, Canada.

Funding

Canadian Cancer Society 701285
6 · The paper itself

Abstract

objectiveExposure to radon causes lung cancer. The scope and impact of exposure among Canadian workers have not been assessed. Our study estimated occupational radon exposure in Canada and its associated lung cancer burden.

methodsExposed workers were identified among the working population during the risk exposure period (1961-2001) using data from the Canadian Census and Labour Force Survey. Exposure levels were assigned based on 12,865 workplace radon measurements for indoor workers and assumed to be 1800 mg/m

resultsApproximately 15.5 million Canadian workers were exposed to radon during the risk exposure period. 79% of exposed workers were exposed to radon levels < 50 Bq/m

conclusionsThe lung cancer burden associated with occupational radon exposure in Canada is small, with the greatest burden occurring among those exposed to low levels of radon.

Indexed as

AdultAgedAged, 80 and overAir Pollution, IndoorCanadaFemaleHumansLung NeoplasmsMaleMiddle AgedMinersNeoplasms, Radiation-InducedOccupational ExposureRadonRadonDisease burdenLung cancerOccupational exposureRadon

Identifiers

PMID32232555
PMCPMC7452915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.